Axsome Therapeutics Stock Price and Value Analysis
Should you buy Axsome Therapeutics stock? (NASDAQ:AXSM). Let's see how it does in our automated value investing analysis system.
| Advantages | Disadvantages | Neutral |
|---|---|---|
|
|
|
Inside the AXSM Numbers
| AXSM Price (Axsome Therapeutics stock price per share) |
$207.77 | |
| [?]
|
PE Ratio versus Sector | 100% lower than other Healthcare stocks |
| [?]
|
PE Ratio versus Industry | 100% lower than other Drug Manufacturers - General stocks |
| [?]
|
Free Cash Flow Jitter | 24% |
Recent Insider Activity
Open-market buys and sells reported by Axsome Therapeutics's officers, directors, and 10% owners on SEC Form 4. Routine transactions (tax withholding, option exercises, and stock grants) are excluded -- these are discretionary trades only.
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-07-01T00:00:00 | TABUTEAU HERRIOT (Chief Executive Officer) | Sell | 49,666 | $240.25 |
| 2026-06-11T00:00:00 | JEFFS ROGER | Sell | 286 | $249.12 |
| 2026-06-10T00:00:00 | Coleman Mark | Sell | 643 | $249.00 |
| 2026-06-10T00:00:00 | JEFFS ROGER | Sell | 286 | $246.18 |
| 2026-06-10T00:00:00 | Mahony Susan | Sell | 300 | $246.18 |
| 2026-06-09T00:00:00 | TABUTEAU HERRIOT (Chief Executive Officer) | Sell | 49,670 | $241.01 |
| 2026-06-09T00:00:00 | Mahony Susan | Sell | 300 | $237.21 |
| 2026-06-09T00:00:00 | Pizzie Nick (Chief Financial Officer) | Sell | 33,000 | $240.09 |
| 2026-06-02T00:00:00 | Coleman Mark | Sell | 5,537 | $223.39 |
| 2026-06-01T00:00:00 | Coleman Mark | Sell | 6,000 | $230.30 |
This stock has short interest! This means that people have shorted it.
Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.
As of the latest analysis, there are 3,407,383 shares shorted. With 44,462,410 shares available for purchase and an average trading volume over the past 10 trading days of 789,040, it would take at least 4.318 days for all of the short holders to cover their shorts.
Is Axsome Therapeutics Stock on Sale?
Based on our analysis, we believe that you should not buy Axsome Therapeutics right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.
Should You Buy AXSM Stock?
Does Axsome Therapeutics have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.